Scarica l'app Stockscreener
11.35
8.10%
-1.00
Dopo l'orario di chiusura:
11.35
Precedente Chiudi:
$12.35
Aprire:
$12.35
Volume 24 ore:
1.94M
Relative Volume:
37.02
Capitalizzazione di mercato:
$424.73M
Reddito:
$59,000
Utile/perdita netta:
$-21.81M
Rapporto P/E:
-1.0364
EPS:
-10.9518
Flusso di cassa netto:
$-18.07M
1 W Prestazione:
-22.31%
1M Prestazione:
-20.74%
6M Prestazione:
-5.42%
1 anno Prestazione:
+60.99%
Intervallo 1D:
$10.91
$12.69
Intervallo di 1 settimana:
$10.91
$15.62
Portata 52W:
$6.765
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Nome
Benitec Biopharma Inc
Settore
Industria
Telefono
(510) 780-0819
Indirizzo
3940 TRUST WAY, HAYWARD, CA
Confronta BNTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
11.35 | 424.73M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-10-16 | Iniziato | Oppenheimer | Outperform |
| 2024-09-12 | Iniziato | Guggenheim | Buy |
| 2024-07-22 | Iniziato | Leerink Partners | Outperform |
| 2024-06-13 | Iniziato | Piper Sandler | Overweight |
| 2020-10-05 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-02-26 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-31 | Reiterato | Maxim Group | Buy |
| 2015-09-16 | Reiterato | Maxim Group | Buy |
Mostra tutto
Benitec Biopharma Inc Borsa (BNTC) Ultime notizie
Trading (BNTC) With Integrated Risk Controls - news.stocktradersdaily.com
GAMMA Investing LLC Grows Stake in Benitec Biopharma Inc. (NASDAQ:BNTC) - Defense World
Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable - Nasdaq
(BNTC) Trading Report - news.stocktradersdaily.com
Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Position Boosted by Ameriprise Financial Inc. - Defense World
Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Form 424B3 Benitec Biopharma Inc. - StreetInsider
Northern Trust Corp Grows Stock Holdings in Benitec Biopharma Inc. (NASDAQ:BNTC) - Defense World
Recent Price Trend in Benitec Biopharma (BNTC) is Your Friend, Here's Why - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid trials - Investing.com Nigeria
(BNTC) Investment Report - news.stocktradersdaily.com
Benitec Biopharma (BNTC) Files to Sell 900K Shares - GuruFocus
Benitec Biopharma (BNTC) Proposes Sale of 900K Common Shares | B - GuruFocus
Benitec Biopharma (BNTC) Proposes Sale of 900K Common Shares | BNTC Stock News - GuruFocus
FY2025 EPS Forecast for Benitec Biopharma Raised by Analyst - Defense World
Wall Street Analysts Think Benitec Biopharma (BNTC) Could Surge 83.91%: Read This Before Placing a Bet - Yahoo Finance
Benitec Biopharma (NASDAQ:BNTC) Receives “Buy” Rating from HC Wainwright - Defense World
Benitec Biopharma (BNTC) Receives Buy Rating from HC Wainwright & Co. | BNTC Stock News - GuruFocus
Are Medical Stocks Lagging Benitec Biopharma (BNTC) This Year? - Yahoo Finance
Leerink Partnrs Issues Optimistic Forecast for BNTC Earnings - Defense World
Benitec Biopharma (NASDAQ:BNTC) Earns Market Outperform Rating from JMP Securities - Defense World
(BNTC) Trading Signals - news.stocktradersdaily.com
Benitec Biopharma (BNTC) Analyst Rating Update from JMP Securities | BNTC Stock News - GuruFocus
Benitec stock holds $20 target, Market Outperform rating - Investing.com
Benitec stock holds $20 target, Market Outperform rating By Investing.com - Investing.com India
Benitec (BNTC) Advances BB-301 Treatment for OPMD with Promising Clinical Progress | BNTC Stock News - GuruFocus
Benitec Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Benitec Biopharma Q3 Operating Income USD -10.2 Million - marketscreener.com
Benitec Biopharma Releases Third Quarter 2025 Financial Results - GuruFocus
Benitec Biopharma reports Q3 EPS (24c) vs. (23c) last year - TipRanks
Benitec Biopharma Inc. SEC 10-Q Report - TradingView
Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2025 - marketscreener.com
Benitec Biopharma (BNTC) Expected to Announce Quarterly Earnings on Monday - Defense World
How To Trade (BNTC) - news.stocktradersdaily.com
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Shares Purchased by Geode Capital Management LLC - Defense World
Wall Street Analysts Believe Benitec Biopharma (BNTC) Could Rally 84.96%: Here's is How to Trade - MSN
What Makes Benitec Biopharma (BNTC) a New Buy Stock - Yahoo Finance
(BNTC) Long Term Investment Analysis - news.stocktradersdaily.com
Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year? - Yahoo Finance
Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha
Benitec Biopharma Inc Azioni (BNTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Benitec Biopharma Inc Azioni (BNTC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
1.11%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):